{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:57:43Z","timestamp":1788814663831,"version":"build-2803163510"},"reference-count":92,"publisher":"Informa UK Limited","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1517\/14656566.2013.799665","type":"journal-article","created":{"date-parts":[[2013,5,16]],"date-time":"2013-05-16T05:15:07Z","timestamp":1368681307000},"page":"1333-1344","source":"Crossref","is-referenced-by-count":88,"title":["An update on pharmacological treatment of erectile dysfunction with phosphodiesterase type 5 inhibitors"],"prefix":"10.1517","volume":"14","author":[{"given":"Roberto","family":"Bruzziches","sequence":"first","affiliation":[{"name":"\u201cSapienza\u201d University of Rome, Endocrinology and Food and Science Section","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Francomano","sequence":"additional","affiliation":[{"name":"\u201cSapienza\u201d University of Rome, Endocrinology and Food and Science Section","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Gareri","sequence":"additional","affiliation":[{"name":"\u201cElderly Health Care\u201d","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lenzi","sequence":"additional","affiliation":[{"name":"\u201cSapienza\u201d University of Rome, Endocrinology and Food and Science Section","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Aversa","sequence":"additional","affiliation":[{"name":"\u201cSapienza\u201d University of Rome, Experimental Medicine Department, Endocrinology and Food and Science Section","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2013,5,16]]},"reference":[{"key":"e_1_3_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.02.020"},{"key":"e_1_3_1_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199805143382001"},{"key":"e_1_3_1_5_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.2011.614435"},{"key":"e_1_3_1_6_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161206778343046"},{"key":"e_1_3_1_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2004.10108.x"},{"key":"e_1_3_1_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/1756287209344992"},{"key":"e_1_3_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmhg.2006.08.007"},{"key":"e_1_3_1_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.332.7541.589"},{"key":"e_1_3_1_11_1","first-page":"117","article-title":"Reasons for discontinuation of sildenafil citrate after successful restoration of erectile function","volume":"6","author":"Son H","year":"2004","unstructured":"Son H, Park K, Kim SW, et al. Reasons for discontinuation of sildenafil citrate after successful restoration of erectile function. Asian J Androl 2004;6:117-20","journal-title":"Asian J Androl"},{"key":"e_1_3_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1098-3597(05)80049-3"},{"key":"e_1_3_1_13_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-7-201304020-00018"},{"key":"e_1_3_1_14_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161208786898734"},{"key":"e_1_3_1_15_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161208786898725"},{"key":"e_1_3_1_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.04042.x"},{"key":"e_1_3_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2006.02.052"},{"key":"e_1_3_1_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2005.20360.x"},{"key":"e_1_3_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2004.10.002"},{"key":"e_1_3_1_20_1","doi-asserted-by":"publisher","DOI":"10.2164\/jandrol.111.015289"},{"key":"e_1_3_1_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2009.01347.x"},{"key":"e_1_3_1_22_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.063412"},{"key":"e_1_3_1_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2012.01.013"},{"key":"e_1_3_1_24_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.110.002907"},{"key":"e_1_3_1_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2004.09.005"},{"key":"e_1_3_1_26_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.3.3.451"},{"key":"e_1_3_1_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11897-012-0121-9"},{"key":"e_1_3_1_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.yic.0000117902.43995.b0"},{"key":"e_1_3_1_29_1","first-page":"23","article-title":"Plasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with systemic sclerosis","volume":"23","author":"Rosato E","year":"2009","unstructured":"Rosato E, Letizia C, Proietti M, et al. Plasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with systemic sclerosis. J Biol Regul Homeost Agents 2009;23:23-9","journal-title":"J Biol Regul Homeost Agents"},{"key":"e_1_3_1_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2008.09.003"},{"key":"e_1_3_1_31_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200464230-00004"},{"key":"e_1_3_1_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2006.01049.x"},{"key":"e_1_3_1_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03343595"},{"key":"e_1_3_1_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3900354"},{"key":"e_1_3_1_35_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.3.3.451"},{"key":"e_1_3_1_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(03)00828-2"},{"key":"e_1_3_1_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(03)00359-5"},{"issue":"5","key":"e_1_3_1_38_1","first-page":"S177","article-title":"Time distribution of sexual intercourse attempts after taking tadalafil or placebo","volume":"15","author":"Shabsigh R","year":"2003","unstructured":"Shabsigh R, Eardley I, Whitaker S, et al. Time distribution of sexual intercourse attempts after taking tadalafil or placebo. Int J Impot Res 2003;15(suppl 5):S177","journal-title":"Int J Impot Res"},{"key":"e_1_3_1_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2003.11.010"},{"key":"e_1_3_1_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3901283"},{"key":"e_1_3_1_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2003.09.023"},{"key":"e_1_3_1_42_1","doi-asserted-by":"publisher","DOI":"10.2174\/157339908783502389"},{"key":"e_1_3_1_43_1","article-title":"Tadalafil once daily improves ejaculatory function, erectile function, and sexual satisfaction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and erectile dysfunction: results from a randomized, placebo- and tamsulosin-controlled, 12-week double-blind study","author":"Giuliano F","year":"2013","unstructured":"Giuliano F, Oelke M, Jungwirth A, et al. Tadalafil once daily improves ejaculatory function, erectile function, and sexual satisfaction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and erectile dysfunction: results from a randomized, placebo- and tamsulosin-controlled, 12-week double-blind study. J Sex Med 2013;doi: 10.1111\/jsm.12039; [Epub ahead of print]","journal-title":"J Sex Med"},{"key":"e_1_3_1_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3901213"},{"key":"e_1_3_1_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-003-0030-2"},{"key":"e_1_3_1_46_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.3.777"},{"key":"e_1_3_1_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000086947.00547.49"},{"key":"e_1_3_1_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2011.02401.x"},{"key":"e_1_3_1_49_1","doi-asserted-by":"publisher","DOI":"10.2165\/11584950-000000000-00000"},{"key":"e_1_3_1_50_1","doi-asserted-by":"publisher","DOI":"10.2165\/11208270-000000000-00000"},{"key":"e_1_3_1_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2010.01806.x"},{"key":"e_1_3_1_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2010.02358.x"},{"key":"e_1_3_1_53_1","first-page":"661","article-title":"Udenafil, a long-acting PDE5 inhibitor for erectile dysfunction","volume":"7","author":"Salem EA","year":"2006","unstructured":"Salem EA, Kendirci M, Hellstrom WJ. Udenafil, a long-acting PDE5 inhibitor for erectile dysfunction. Curr Opin Investig Drugs 2006;7:661-9","journal-title":"Curr Opin Investig Drugs"},{"key":"e_1_3_1_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2012.02.014"},{"key":"e_1_3_1_55_1","unstructured":"US Food and Drug Administration. FDA approves Stendra for erectile dysfunction. Available from: http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm302140.htm [Accessed 1 May2012]"},{"key":"e_1_3_1_56_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S15852"},{"key":"e_1_3_1_57_1","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S26712"},{"key":"e_1_3_1_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2009.06.008"},{"key":"e_1_3_1_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/jlcr.1116"},{"key":"e_1_3_1_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.2943"},{"issue":"5","key":"e_1_3_1_61_1","first-page":"393","article-title":"Efficacy and safety of oral SK3530 in the treatment of men in Korea with erectile dysfunction: a multicentre, randomized, double-blind, placebo-controlled, fixed dose, parallel group clinical trial","volume":"3","author":"Paick JS","year":"2006","unstructured":"Paick JS, Choi HK, Kim SC, et al. Efficacy and safety of oral SK3530 in the treatment of men in Korea with erectile dysfunction: a multicentre, randomized, double-blind, placebo-controlled, fixed dose, parallel group clinical trial. J Sex Med 2006;3(5 suppl):393","journal-title":"J Sex Med"},{"key":"e_1_3_1_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2008.00945.x"},{"key":"e_1_3_1_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2009.01375.x"},{"key":"e_1_3_1_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2012.02667.x"},{"key":"e_1_3_1_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12130"},{"key":"e_1_3_1_66_1","doi-asserted-by":"publisher","DOI":"10.4111\/kju.2007.48.2.219"},{"key":"e_1_3_1_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(03)80328-4"},{"key":"e_1_3_1_68_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2490-5-18"},{"key":"e_1_3_1_69_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-9-200911030-00150"},{"key":"e_1_3_1_70_1","volume-title":"Health","author":"CAfDaTi","year":"2010","unstructured":"Canadian Agency for Drugs and Technologies in Health. Phosphodiesterase 5 inhibitors: a review of the clinical effectiveness and cost-effectiveness. In: CAfDaTi, editor. Health. Ottawa: 2010"},{"key":"e_1_3_1_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.01.012"},{"key":"e_1_3_1_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2007.00688.x"},{"key":"e_1_3_1_73_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3901252"},{"key":"e_1_3_1_74_1","first-page":"117","article-title":"Reasons for discontinuation of sildenafil citrate after successful restoration of erectile function","volume":"6","author":"Son H","year":"2004","unstructured":"Son H, Park K, Kim SC, et al. Reasons for discontinuation of sildenafil citrate after successful restoration of erectile function. Asian J Androl 2004;6:117-20","journal-title":"Asian J Androl"},{"key":"e_1_3_1_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3901379"},{"key":"e_1_3_1_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2007.08.016"},{"key":"e_1_3_1_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2012.02787.x"},{"key":"e_1_3_1_78_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2011.02473.x"},{"key":"e_1_3_1_79_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2011.02611.x"},{"key":"e_1_3_1_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2006.01.028"},{"key":"e_1_3_1_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2003.11.020"},{"key":"e_1_3_1_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2007.00712.x"},{"key":"e_1_3_1_83_1","first-page":"101","article-title":"Cardiovascular effect of testosterone replacement therapy in aging male","volume":"81","author":"Francomano D","year":"2010","unstructured":"Francomano D, Bruzziches R, Natali M, et al. Cardiovascular effect of testosterone replacement therapy in aging male. Acta Biomed 2010;81:Suppl 1:101-6","journal-title":"Acta Biomed"},{"key":"e_1_3_1_84_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.332.7541.589"},{"key":"e_1_3_1_85_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200565120-00003"},{"key":"e_1_3_1_86_1","doi-asserted-by":"publisher","DOI":"10.1002\/nau.20999"},{"key":"e_1_3_1_87_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2011.609315"},{"key":"e_1_3_1_88_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2042.2009.02426.x"},{"key":"e_1_3_1_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2012.06.015"},{"key":"e_1_3_1_90_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e32834b79e6"},{"key":"e_1_3_1_91_1","doi-asserted-by":"crossref","unstructured":"Borer J Armstrong P. Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee. Proceedings of the 99th meeting of the Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee; May 29th and 30th 2003; Circulation 2003. 107: e9052","DOI":"10.1161\/01.CIR.0000082691.46188.C8"},{"key":"e_1_3_1_92_1","doi-asserted-by":"publisher","DOI":"10.2164\/jandrol.111.015289"},{"key":"e_1_3_1_93_1","doi-asserted-by":"publisher","DOI":"10.1038\/ijir.2009.21"},{"key":"e_1_3_1_94_1","doi-asserted-by":"crossref","unstructured":"Francomano D Donini LM Lenzi A Aversa A. Peripheral arterial tonometry to measure the effects of Vardenafil on sympathetic tone in men with lifelong premature ejaculation. Int J Endocrinol 2013.2013 Article ID 394934 9 pages. Available from: http:\/\/dx.doi.org\/10.1155\/2013\/394934","DOI":"10.1155\/2013\/394934"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14656566.2013.799665","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T02:43:57Z","timestamp":1772765037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14656566.2013.799665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,16]]},"references-count":92,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["10.1517\/14656566.2013.799665"],"URL":"https:\/\/doi.org\/10.1517\/14656566.2013.799665","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,16]]}}}